Skip to main content
Equibles

Meridian Wealth Management, LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1697300 LEXINGTON, KY
Back to AXSM Full portfolio

Position in AXSM

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$5,391,793
+$1,669,297 QoQ
Shares Held
22,028
+0.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#165
of 504 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 75% Shared 0% None 25%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Meridian Wealth Management, LLC holds $7,258,442 across 7 Biotechnology names. AXSM ranks #1 (74.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
This page 		22,028 $5,391,793
2 NUVB
Nuvation Bio Inc.
 132,256 $751,214
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 742 $368,573
4 DMAC
DiaMedica Therapeutics Inc.
 43,600 $306,944
5 LGND
Ligand Pharmaceuticals Inc
 801 $253,188
6 NMRA
Neumora Therapeutics, Inc.
 94,400 $160,480
7 BYSI
BeyondSpring Inc.
 15,000 $26,250

All Filings in AXSM

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,391,793 22,028
2026-03-31 $3,722,496 22,024
2025-12-31 $3,967,671 21,724
2025-09-30 $2,686,959 22,124
2025-06-30 $2,298,772 22,021
2025-03-31 $2,451,679 21,021
2024-12-31 $1,791,278 21,171
2024-09-30 $1,889,157 21,021
2024-06-30 $1,695,008 21,056
2023-12-31 $1,631,435 20,498
2023-09-30 $1,343,495 19,223
2023-06-30 $1,363,399 18,973
2023-03-31 $1,016,054 16,473
2022-12-31 $1,152,939 14,948
2022-09-30 $583,183 13,070
2022-06-30 $303,719 7,930